Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Bruno Oesch | M | - |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | 14 Jahre |
| Mauro Massimo Sette | M | - |
Medyria AG
 Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | 12 Jahre |
| Peter Anton Joseph Kurer | M | 75 |
Kein & Aber AG
 Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland.
University of Zurich
| 14 Jahre |
| Irene Schiller | M | - |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | 14 Jahre |
| Peter George Haag | M | - |
Kein & Aber AG
Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland. | 27 Jahre |
| Berini Gian-Luigi | M | - |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
| Giovanni Leo | M | - |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
| Eric le Royer | M | 61 |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
| Andrea Thaddaus Vasella | M | 81 |
University of Zurich
| 43 Jahre |
| Anita di Iasio | F | - |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
| David Gerber | M | - |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | - |
| Daniel Dark | M | - |
Kein & Aber AG
Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland. | - |
| Viktor Giacobbo | M | - |
Kein & Aber AG
Kein & Aber AG Publishing: Books/MagazinesConsumer Services Kein & Aber AG engages in publishing books. It publishes books, pocketbooks, electronic books, digital versatile disc's, gift books, and pics and picks. The company was founded by Peter George Haag on June 26, 1992 and is headquartered in Zurich, Switzerland. | - |
| Hans Van de venn | M | - |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
| Renato Mattli | M | - |
Medyria AG
Medyria AG BiotechnologyHealth Technology Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Johannes A. de Gier | M | 80 |
Julius Baer Holding AG
| 3 Jahre |
| Markus Dennler | M | 68 |
University of Zurich
| 5 Jahre |
| Rolf P. Jetzer | M | 73 |
Julius Baer Holding AG
University of Zurich
| 4 Jahre |
| Ivo Furrer | M | 67 |
University of Zurich
| 6 Jahre |
| Hans Wehrli | M | 72 |
University of Zurich
| 7 Jahre |
| Markus Vischer | M | 64 |
University of Zurich
| - |
| Christoph Schmid | M | 70 |
University of Zurich
| 7 Jahre |
| François Meyer | M | 76 |
University of Zurich
| 3 Jahre |
| Jürg Sturzenegger | M | 63 |
University of Zurich
| 6 Jahre |
| Andreas Kleeb | M | 61 |
University of Zurich
| 5 Jahre |
| Urs Mäder | M | 68 |
University of Zurich
| 4 Jahre |
| Rudolf Marty | M | 75 |
University of Zurich
| 10 Jahre |
| Markus Isenrich | M | 71 |
University of Zurich
| 3 Jahre |
| Beat Bernet | M | 69 |
University of Zurich
| 3 Jahre |
| Paul Schneider | M | 69 |
University of Zurich
| 1 Jahre |
| Thomas Wetzel | M | 67 |
University of Zurich
| 3 Jahre |
| Ralph Max Büchi | M | 67 |
University of Zurich
| 4 Jahre |
| Roland Moser | M | - |
Julius Baer Holding AG
| 1 Jahre |
| Daniel Sigg | M | 67 |
University of Zurich
| 3 Jahre |
| Markus Schnurrenberger | M | - |
University of Zurich
| 5 Jahre |
| Adrian Rüesch | M | 70 |
University of Zurich
| 3 Jahre |
| Peter Karlheinz Beck | M | - |
University of Zurich
| 4 Jahre |
| Patrick K. Oesch | M | 66 |
University of Zurich
| 3 Jahre |
| Patrizia Holenstein | M | 67 |
University of Zurich
| 4 Jahre |
| Stefan Breitenstein | M | 67 |
University of Zurich
| 4 Jahre |
| Ingrid Deltenre | F | 64 |
University of Zurich
| 7 Jahre |
| Walter Locher | M | 69 |
University of Zurich
| 3 Jahre |
| Ulrich Schluer | M | 80 |
University of Zurich
| 3 Jahre |
| Schlumpf Widmer-Schlumpf | F | 68 |
University of Zurich
| 4 Jahre |
| Rudolf Heinrich Escher | M | 67 |
University of Zurich
| 4 Jahre |
| Erich Bohli | M | 74 |
University of Zurich
| 3 Jahre |
| Mauro dell'Ambrogio | M | - |
University of Zurich
| 3 Jahre |
| Bernhard Hodler | M | 64 |
Julius Baer Holding AG
| 8 Jahre |
| Martin M. Naville | M | 65 |
University of Zurich
| 5 Jahre |
| Hans Baumgartner | M | 70 |
University of Zurich
| 3 Jahre |
| Jakob Höhn | M | 64 |
University of Zurich
| 3 Jahre |
| Thomas Rudolf Eichler | M | 69 |
University of Zurich
| 3 Jahre |
| Urs Rohner | M | 65 |
University of Zurich
| 3 Jahre |
| Renato Fassbind | M | 69 |
University of Zurich
| 3 Jahre |
| Peter Küpfer | M | 80 |
Julius Baer Holding AG
| 10 Jahre |
| Thomas Knöpfel | M | 73 |
University of Zurich
| 3 Jahre |
| Daniel Obrecht | M | 69 |
University of Zurich
| 3 Jahre |
| Thomas H. Eckelmann | M | 73 |
University of Zurich
| 4 Jahre |
| Stephen Rietiker | M | 67 |
University of Zurich
| 3 Jahre |
| Andreas R. Spahni | M | 66 |
University of Zurich
| 4 Jahre |
| Andrew C. Weiss | M | 55 |
Julius Baer Holding AG
| 5 Jahre |
| Reto Francioni | M | 68 |
University of Zurich
| 2 Jahre |
| Krzysztof Opawski | M | 74 |
University of Zurich
| 1 Jahre |
| Bernhard M. Hammer | M | 73 |
University of Zurich
| 3 Jahre |
| Rodolfo Straub | M | - |
University of Zurich
| 3 Jahre |
| Rudolf Wehrli | M | 75 |
University of Zurich
| 2 Jahre |
| Dieter A. Enkelmann | M | 65 |
University of Zurich
| 3 Jahre |
| Bjoern Bajan | M | 64 |
University of Zurich
| 4 Jahre |
| Gaudenz F. Domenig | M | 68 |
University of Zurich
| 2 Jahre |
| Rudolf Huber | M | 69 |
University of Zurich
| 6 Jahre |
| Peter Ilg | M | 58 |
University of Zurich
| 4 Jahre |
| Jörg Zulauf | M | 66 |
University of Zurich
| 3 Jahre |
| Rudolf W. Fischer | M | 72 |
University of Zurich
| 3 Jahre |
| Felix R. Ehrat | M | 67 |
University of Zurich
| 3 Jahre |
| Karl Hofstetter | M | 68 |
University of Zurich
| 3 Jahre |
| Markus K. Christen | M | - |
University of Zurich
| 3 Jahre |
| Michel Streuli | M | - |
University of Zurich
| 7 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Schweiz | 77 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
